Outpatient prostatitis single-agent therapy includes which option?

Outpatient prostatitis single-agent therapy includes which option?

• A. Quinolone
• B. Bactrim
• C. Amoxicillin
• D. Doxycycline

Answer: (B)

The key idea is using an oral antibiotic that reaches high levels in the prostate and covers the common pathogens that cause outpatient prostatitis. Trimethoprim-sulfamethoxazole (Bactrim) fits this well: it penetrates prostatic tissue and fluid effectively and is active against many Enterobacterales, including E. coli, which are typical culprits. That makes it a solid single-agent option for outpatient treatment. Amoxicillin usually isn’t reliable for prostatitis because many prostate-infecting bacteria are resistant or produce enzymes that inactivate it, and it doesn’t consistently achieve therapeutic prostatic levels. Doxycycline isn’t the best single-agent choice for the usual prostatitis pathogens either, as its activity and penetration are less reliable in this setting. Quinolones are also effective and commonly used, but among the options listed, trimethoprim-sulfamethoxazole provides robust coverage with good prostatic penetration as a single agent.

The key idea is using an oral antibiotic that reaches high levels in the prostate and covers the common pathogens that cause outpatient prostatitis. Trimethoprim-sulfamethoxazole (Bactrim) fits this well: it penetrates prostatic tissue and fluid effectively and is active against many Enterobacterales, including E. coli, which are typical culprits. That makes it a solid single-agent option for outpatient treatment.

Amoxicillin usually isn’t reliable for prostatitis because many prostate-infecting bacteria are resistant or produce enzymes that inactivate it, and it doesn’t consistently achieve therapeutic prostatic levels. Doxycycline isn’t the best single-agent choice for the usual prostatitis pathogens either, as its activity and penetration are less reliable in this setting. Quinolones are also effective and commonly used, but among the options listed, trimethoprim-sulfamethoxazole provides robust coverage with good prostatic penetration as a single agent.